Real-Time Biopsies Reveal Hidden Insights into Glioblastoma Therapy Response

October 08, 2025
In a groundbreaking advancement for glioblastoma research, scientists from Break Through Cancer’s Accelerating Glioblastoma Therapies Through Serial Biopsies TeamLab have demonstrated that the oncolytic virus therapy, CAN-3110, sparks a profound and previously undetectable immune response deep within recurrent glioblastoma tumors.

Read More at Bioengineer.org

UPDATES ANDΒ NEWS

Media Coverage

Why some family offices are becoming cancer research’s new bankrollers | Crain Currency

Media Coverage

𝖑𝗋𝖾𝖺𝗄 π˜›π˜©π˜³π˜°π˜Άπ˜¨π˜© 𝖒𝖺𝗇𝖼𝖾𝗋’π—Œ Tyler Jacks: β€œWe’ve created a new operating model for collaborative cancer research.

Insights & Updates

2025 Year in Review: Our Scientific Progress and Clinical Impact

Press Release

New Coalition of Leading Cancer Research Organizations Launched to Accelerate Early Detection of Deadly Cancers

View All

BE PART OF THE MISSION
Stay Informed, Make an Impact

Subscribe

Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.

* indicates required
Email Format

Give

Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.

Media Coverage
6 likes